March 18, 2021: Improving viral suppression among PLWH experiencing homelessness; co-located PrEP services for trans women; subsidized health care and PrEP uptake; Heplisav-B hepatitis B vaccine efficacy in PLWH.
April 15, 2021: Alcohol and neurocognitive impairment; using hair analysis to measure substance use; integrase inhibitors' impact on verbal learning; hepatocellular carcinoma trends among PLWH.
April 8, 2021: PrEP “contemplation” and uptake among adolescents; adolescent perception of HIV risk; HIV diagnosis rates among transgender people; PrEP and HIV incidence in Scotland.
April 1, 2021: The ethics of teaching U=U; the role of primary care in HIV service acceptance; STI testing rates in transgender women; the potential in anal self-sampling.
March 25, 2021: HIV disease progression spikes in a London hospital; neurocognitive impairment and frailty in PLWH; the smell of HIV-associated neurocognitive disorder; statin usage and physical function decline.
March 11, 2021: Anticholinergic medications and neurocognitive issues; weight gain and dolutegravir in older men; drug interaction risks on B/F/TAF; real-world efficacy of HBV-active HIV treatment.
March 4, 2021: Improving care for PLWH in transition from incarceration; long-acting PrEP's potential in Black and Latinx communities; comorbidity rates and COVID-19 risk among PLWH; how COVID lockdowns affect the HIV epidemic.
Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.
Feb. 18, 2021: Insomnia rates among PLWH; trends in multimorbidity diagnosis; viral load control loss in the modern HIV treatment era; acceptability of HIV self-test dissemination methods.
Feb. 11, 2021: Early comorbidity development among women living with HIV; type 2 heart attack frequency; assessing European-based CVD assessment tools; long-term cognitive dysfunction and HIV/hepatitis coinfection.
Feb. 4, 2021: STI rates among PrEP users; how Medicaid expansion affects HIV testing and PrEP rates; utilizing mental health care providers in PrEP uptake; adapting HIV care in the COVID era.